Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenoldopam for Renal Replacement Therapy Reduction After Cardiac Surgery
NCT00621790Phase 3Completed
- Sponsor
- Vita-Salute San Raffaele University
- Start
- Feb 2008
- Primary completion
- Jun 2013
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute kidney injury (AKI) comparing Fenoldopam with Placebo (2 arms). Primary endpoint: Number of patients requiring Renal Replacement Therapy. Started Feb 2008; status: completed.
02
Drugs
fenoldopam
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT00621790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00621790.